TRIEU VUONG (CEO and Chairman of the Board) purchased 0.1% of their position (120K shares) of ONCOTELIC THERAPEUTICS, INC. on the open market
Open‑market purchase worth $6.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/7/2022ACC: 0001493152-22-034663
DirectorOfficer10% Owner· CEO and Chairman of the Board
Since Apr 2019
+120K
Net shares
Net buyer
$6.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
120K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+120K
Price / share
$0.05
Trade value
$6K
% of position
0.1%
12/6/2022
90.44M→90.56M
Total
Net shares
+120K
Net value
$6K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/6/2022 | P · Purchase | +120K | $0.05 | $6K | 0.1% | 90.44M | 90.56M |
| Total | +120K | $6K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned16.78M
Common Stock
IndirectShares owned6.87M
Total
23.65M indirect23.65M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 16.78M | Indirect |
| Common Stock | 6.87M | Indirect |
| Total | 23.65M | 23.65M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported